Nordea Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $227M | Buy |
363,479
+269,157
| +285% | +$183M | 0.19% | 125 |
|
|
2026
Q1 | $72.4M | Sell |
94,322
-42,999
| -31% | -$32.9M | 0.07% | 232 |
|
|
2025
Q4 | $106M | Buy |
137,321
+74,350
| +118% | +$50.5M | 0.09% | 206 |
|
|
2025
Q3 | $35.1M | Buy |
62,971
+15,983
| +34% | +$9.04M | 0.03% | 300 |
|
|
2025
Q2 | $24.5M | Buy |
46,988
+2,768
| +6% | +$1.54M | 0.02% | 314 |
|
|
2025
Q1 | $28M | Buy |
44,220
+1,553
| +4% | +$1.07M | 0.03% | 303 |
|
|
2024
Q4 | $30.2M | Buy |
42,667
+8,135
| +24% | +$6.83M | 0.03% | 294 |
|
|
2024
Q3 | $36.4M | Sell |
34,532
-10,729
| -24% | -$11.9M | 0.04% | 280 |
|
|
2024
Q2 | $47.4M | Buy |
45,261
+16,066
| +55% | +$15.6M | 0.06% | 260 |
|
|
2024
Q1 | $28.2M | Buy |
29,195
+5,495
| +23% | +$5.23M | 0.03% | 312 |
|
|
2023
Q4 | $20.9M | Sell |
23,700
-87
| -0.4% | -$71.6K | 0.03% | 323 |
|
|
2023
Q3 | $19.7M | Sell |
23,787
-1,364
| -5% | -$1.07M | 0.03% | 302 |
|
|
2023
Q2 | $17.8M | Sell |
25,151
-419
| -2% | -$323K | 0.02% | 322 |
|
|
2023
Q1 | $21M | Buy |
25,570
+349
| +1% | +$263K | 0.03% | 286 |
|
|
2022
Q4 | $18M | Sell |
25,221
-964
| -4% | -$711K | 0.03% | 302 |
|
|
2022
Q3 | $18.2M | Sell |
26,185
-6,194
| -19% | -$3.9M | 0.03% | 299 |
|
|
2022
Q2 | $19M | Sell |
32,379
-16,491
| -34% | -$10.7M | 0.03% | 304 |
|
|
2022
Q1 | $34.4M | Sell |
48,870
-2,206
| -4% | -$1.4M | 0.04% | 273 |
|
|
2021
Q4 | $32.8M | Sell |
51,076
-967
| -2% | -$595K | 0.04% | 284 |
|
|
2021
Q3 | $31.9M | Buy |
52,043
+1,190
| +2% | +$739K | 0.04% | 292 |
|
|
2021
Q2 | $28.4M | Buy |
50,853
+469
| +0.9% | +$238K | 0.04% | 299 |
|
|
2021
Q1 | $23.8M | Buy |
50,384
+2,270
| +5% | +$1.11M | 0.03% | 303 |
|
|
2020
Q4 | $23.2M | Buy |
48,114
+4,573
| +11% | +$2.47M | 0.04% | 290 |
|
|
2020
Q3 | $25M | Sell |
43,541
-365
| -0.8% | -$221K | 0.05% | 260 |
|
|
2020
Q2 | $27.1M | Buy |
43,906
+28,313
| +182% | +$16.1M | 0.03% | 291 |
|
|
2020
Q1 | $7.25M | Sell |
15,593
-104
| -0.7% | -$42.9K | 0.02% | 355 |
|
|
2019
Q4 | $5.89M | Buy |
15,697
+57
| +0.4% | +$19.2K | 0.01% | 427 |
|
|
2019
Q3 | $4.31M | Buy |
15,640
+90
| +0.6% | +$26.6K | 0.01% | 566 |
|
|
2019
Q2 | $4.87M | Buy |
15,550
+2,164
| +16% | +$720K | 0.01% | 488 |
|
|
2019
Q1 | $5.49M | Buy |
13,386
+9,171
| +218% | +$3.78M | 0.01% | 524 |
|
|
2018
Q4 | $1.57M | Hold |
4,215
| – | – | ﹤0.01% | 883 |
|
|
2018
Q3 | $1.7M | Buy |
4,215
+64
| +2% | +$24.4K | ﹤0.01% | 914 |
|
|
2018
Q2 | $1.43M | Sell |
4,151
-20,720
| -83% | -$6.48M | ﹤0.01% | 783 |
|
|
2018
Q1 | $8.56M | Sell |
24,871
-760
| -3% | -$264K | 0.02% | 338 |
|
|
2017
Q4 | $9.64M | Sell |
25,631
-2,839
| -10% | -$1.15M | 0.02% | 301 |
|
|
2017
Q3 | $12.7M | Sell |
28,470
-5,634
| -17% | -$2.68M | 0.03% | 259 |
|
|
2017
Q2 | $16.8M | Sell |
34,104
-5,168
| -13% | -$2.26M | 0.04% | 219 |
|
|
2017
Q1 | $15.2M | Buy |
39,272
+760
| +2% | +$282K | 0.04% | 223 |
|
|
2016
Q4 | $14.1M | Buy |
38,512
+6,162
| +19% | +$2.34M | 0.04% | 243 |
|
|
2016
Q3 | $13M | Sell |
32,350
-914
| -3% | -$367K | 0.03% | 246 |
|
|
2016
Q2 | $11.6M | Buy |
33,264
+9,480
| +40% | +$3.65M | 0.03% | 231 |
|
|
2016
Q1 | $8.57M | Buy |
23,784
+20,857
| +713% | +$8.59M | 0.03% | 251 |
|
|
2015
Q4 | $1.59M | Sell |
2,927
-50
| -2% | -$27.1K | 0.01% | 458 |
|
|
2015
Q3 | $1.39M | Buy |
2,977
+266
| +10% | +$143K | 0.01% | 395 |
|
|
2015
Q2 | $1.38M | Buy |
2,711
+129
| +5% | +$63K | ﹤0.01% | 393 |
|
|
2015
Q1 | $1.17M | Hold |
2,582
| – | – | ﹤0.01% | 431 |
|
|
2014
Q4 | $1.06M | Sell |
2,582
-499
| -16% | -$196K | ﹤0.01% | 470 |
|
|
2014
Q3 | $1.11M | Sell |
3,081
-881
| -22% | -$295K | ﹤0.01% | 483 |
|
|
2014
Q2 | $1.12M | Sell |
3,962
-1,496
| -27% | -$443K | ﹤0.01% | 534 |
|
|
2014
Q1 | $1.64M | Sell |
5,458
-1,174
| -18% | -$362K | 0.01% | 463 |
|
|
2013
Q4 | $1.82M | Buy |
6,632
+392
| +6% | +$113K | 0.01% | 452 |
|
|
2013
Q3 | $1.95M | Hold |
6,240
| – | – | 0.01% | 439 |
|
|
2013
Q2 | $1.4M | Buy |
+6,240
| New | +$1.45M | 0.01% | 510 |
|
Other funds holding REGN
Nordea Investment Management's REGN Position: Q2 2026 in Review
Nordea Investment Management increased its Regeneron Pharmaceuticals (REGN) stake by 285% in Q2 2026, buying an estimated $183M and bringing the position to 363,479 shares worth $227M. The position accounts for 0.19% of the portfolio, ranked #125.
Nordea Investment Management first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Nordea Investment Management held 363,479 shares of Regeneron Pharmaceuticals worth $227M as of Q2 2026.
- Nordea Investment Management bought 269,157 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $183M.
- Regeneron Pharmaceuticals made up 0.19% of Nordea Investment Management's portfolio in Q2 2026, its #125 holding.
- Nordea Investment Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Nordea Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.